PubMed · 2003 · 45 citations · 41 references
MedicineOncologyPathologyCutaneous OncologyMetastasisSignal TransductionCancer Cell SignalingMalignant NeoplasmsMalignant TumorsMelanocytic LesionsMelanocytic TumorsTumor CharacterizationActivationBenign Melanocytic LesionsBenign Melanocytic TumorsExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingNodular MelanomaProtein Expression BiomarkersSuperficial Spreading Melanoma
PURPOSE: The purpose of the present work was to analyze the protein expression of activated extracellular signal-regulated kinases 1 and 2 (ERK1/2) in a panel of superficial spreading (SSM) and nodular (NM) primary and metastatic melanomas, and to correlate the expression level with clinicopathological parameters. EXPERIMENTAL DESIGN: Expression of activated ERK1/2 was examined by immunohistochemistry in 172 primary melanomas (108 SSM and 64 NMs), 67 metastatic lesions, and in 41 benign nevi. RESULTS: Fifty four percent of primary and 33% of metastatic melanomas expressed variable levels of activated ERK1/2. No immunoreactivity was detected in benign nevi. In 21% of the primaries only cytoplasmic expression was detected, whereas 3% and 30% showed positive immunoreactivity in either nucleus or cytoplasm and nucleus, respectively. Activated ERK1/2 expression varied significantly with the thickness of superficial spreading melanomas, with lower expression in thinner lesions (P = 0.016). A significant correlation between activated ERK1/2 and cyclin D1 (P = 0.031) in nodular, as well as between activated ERK1/2 and cyclin D3 (P = 0.030) in SSMs were observed. The protein level of p27(Kip1) correlated with activated ERK1/2 (P = 0.048) in the nucleus. Furthermore, a strong inverse correlation between activated ERK1/2 and membrane-bound beta-catenin (P = 0.004) in nodular melanomas was revealed. Activation of ERK1/2 did not have any impact on relapse-free or overall survival. CONCLUSION: Our results suggest that activation of ERK1/2 may be involved in cell cycle regulation in SSMs. Moreover, the inverse association between membrane-bound beta-catenin and ERK1/2 in NMs suggest that ERK1/2 activation may play a role in decreasing homotypic interactions through destabilization of beta-catenin.
41
Mutations of the BRAF gene in human cancer
Helen Davies, Graham R. Bignell, Charles Cox et al. · Nature · 2002 · 10.7K citations
Transformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
Sam J. Mansour, Wayne T. Matten, April S. Hermann et al. · Science · 1994 · 1.4K citations
Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)
Sven Zimmermann, Karin Moelling · Science · 1999 · 1.1K citations